Phathom Pharmaceuticals (PHAT) P/E (2019 - 2026)
Phathom Pharmaceuticals (PHAT) P/E from Oct 25, 2019 to Jul 21, 2026. The TTM Phathom Pharmaceuticals (PHAT) P/E is -5.16. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Phathom Pharmaceuticals (PHAT)
| Year | P/E | Change |
|---|---|---|
| 2026 | -5.16 | -1.97% |
| 2025 | -5.26 | +223.26% |
| 2024 | -1.63 | -35.95% |
| 2023 | -2.54 | +9.92% |
| 2022 | -2.31 | -34.64% |
| 2021 | -3.54 | -48.65% |
| 2020 | -6.89 | +81.99% |
| 2019 | -3.78 | N/A |
Comparison Phathom Pharmaceuticals (PHAT) P/E with competitors
Phathom Pharmaceuticals (PHAT) P/E is -5.16.